Cme Group (CME) Research & Development: 2009-2025
Historic Research & Development for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $71.4 million.
- Cme Group's Research & Development rose 7.21% to $71.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.7 million, marking a year-over-year increase of 10.10%. This contributed to the annual value of $255.8 million for FY2024, which is 16.96% up from last year.
- Per Cme Group's latest filing, its Research & Development stood at $71.4 million for Q3 2025, which was up 0.71% from $70.9 million recorded in Q2 2025.
- In the past 5 years, Cme Group's Research & Development ranged from a high of $71.4 million in Q3 2025 and a low of $45.8 million during Q4 2021.
- Over the past 3 years, Cme Group's median Research & Development value was $64.1 million (recorded in 2024), while the average stood at $62.0 million.
- In the last 5 years, Cme Group's Research & Development declined by 14.55% in 2021 and then climbed by 20.26% in 2024.
- Cme Group's Research & Development (Quarterly) stood at $45.8 million in 2021, then increased by 9.17% to $50.0 million in 2022, then grew by 17.00% to $58.5 million in 2023, then increased by 12.31% to $65.7 million in 2024, then grew by 7.21% to $71.4 million in 2025.
- Its Research & Development stands at $71.4 million for Q3 2025, versus $70.9 million for Q2 2025 and $65.7 million for Q1 2025.